Home
Abbvie Contract Manufacturing

Abbvie Contract Manufact... Market Share Analysis for November 2025

abbvie contract manufacturing has a track record of successful small molecule and biologics development, giving your project a strategic head start.

Health > Biotechnology and Pharmaceuticals

Domainabbviecontractmfg.com

Year Founded--

Employees> 10001

Annual Revenue--

Abbvie Contract Manufacturing

Abbvie Contract Manufacturing (including company regionals)

abbviecontractmfg.com

See more website traffic and engagement information

Total visits to Abbvie Contract Manufacturing's top domains

Understand Abbvie Contract Manufacturing market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abbviecontractmfg.com11.5K

See more with Sales Intelligence

Avg. visit duration in Abbvie Contract Manufacturing's top domains

Analyze Abbvie Contract Manufacturing engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abbviecontractmfg.com00:00:25

See more with Sales Intelligence

Avg. pageviews on Abbvie Contract Manufacturing's top domains

See how Abbvie Contract Manufacturing keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abbviecontractmfg.com1.66

See more with Sales Intelligence

Abbvie Contract Manufacturing top competitors by domain

Top similar sites in November 2025, ranked by their affinity

adragos-pharma.comCompany NameAdragos Pharma GmbHEmployees201 - 500HQGermany, MunchenAnnual revenue$5M - $10MTotal visits25.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Abbvie Contract Manufacturing

These are the website technologies, by industry, used by Abbvie Contract Manufacturing top domains

Advertising (13)

Google Adsense

Conversion & Analytics (7)

Google Analytics

Marketing (3)

Google Marketing Platform

Audio Video Media (2)

VideoJS

More Technologies

5

See all

News & Signals from Abbvie Contract Manufacturing

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbbVie Inc. invested into assets: manufacturing plant in the amount of $223M on Jan 1st '24.Back in January, AbbVie said it broke ground on a $223 million expansion of its manufacturing plant in the country to help bolster global biologics capacity.

NewsAbbVie Inc. partnered with Umoja Biopharma, Inc. on Jan 28th '24.Last month, AbbVie also inked two contracts with Seattle-based biotech Umoja Biopharma to develop several in-situ CAR-T therapies against various cancers.

NewsAbbVie Inc. acquired Stemcentrx, Inc. for $5.8B on Jun 1st '16.In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash-and-stock deal worth $5.8 billion.